ELVN
Enliven Therapeutics, Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:59:52 PM EST
44.91USD-4.141%(-1.94)747,613
After-hoursNov 18, 2026 4:00:30 PM EST
44.89USD-0.045%(-0.02)
ELVN News
Enliven Therapeutics GAAP EPS of -$0.36 ·
Seeking Alpha
Enliven Therapeutics CFO Hohl sells $231,545 in shares ·
Investing.com
Enliven Therapeutics CMO Collins sells $192,342 in ELVN stock ·
Investing.com
H.C. Wainwright raises Enliven Therapeutics price target to $73 ·
Investing.com
Enliven Therapeutics appoints Kristine Ball to board ·
Investing.com
Enliven Therapeutics director Scott Garland sells $606k in stock ·
Investing.com
FDA agrees ENABLE-2 Phase III trial design for Enliven’s relcobatinib ·
Clinical Trials Arena
These ten healthcare stocks posted the biggest one-month losses ·
Seeking Alpha